13:30 - 14:15

Day 1 – February 1, 2023


Marie-Christine Bene

Initiated by Gerrit Jan Schuurhuis, a group of European LeukmiaNet members met to share experience on minimal/measurable residual disease (MRD) in acute myeloblastic leukemia. This gave rise to a seminal paper in 2018 with more recent revisions. This group has dealt with MRD in flow cytometry as well as with molecular tools as well as with clinical applications.

The speakers